Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Mario Tama via Getty
Moderna's coronavirus vaccine will provide immunity from the disease for at least one year, the biotech company said Monday per Reuters.
Why it matters: Moderna's vaccine is one of two now authorized for emergency use in the U.S., as coronavirus cases surge past 22.5 million nationally and 90.8 million globally.
The big picture: Moderna expects to deliver around 600 million to 1 billion doses in 2021.
- The U.S. has purchased a total of 200 million doses from Moderna.
- The company has signed agreements with several other countries including Japan, Canada and Israel, boosting hope as the number of global cases nears 91 million.
- The United Kingdom and the EU's European Medicines Agency approved the vaccine this week.
Yes, but: The World Health Organization cautioned on Monday that herd immunity is unlikely this year despite the vaccine rollout in countries around the world.
Editor's note: The headline has been clarified to reflect at least one year of immunization.